Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cerevast Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cerevast Therapeutics

Cerevast Therapeutics

Cerevast Therapeutics provides non-invasive SonoLysis therapy for vascular disorders using proprietary technology.

HQ
Redmond, WA, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Cerevast Therapeutics, founded in September 2009, is a medical technology company focused on developing non-invasive SonoLysis therapies for treating acute ischemic stroke and other vascular disorders. Their flagship product, the ClotBust-ERTM, is an ultrasonic headframe designed to be easily deployed by emergency room staff to administer ultrasound energy for SonoLysis therapy. The company aims to revolutionize emergency stroke treatment with its operator-independent device, ensuring rapid and safe intervention.

Notable figures associated with Cerevast include its experienced management team and board of directors, who bring extensive expertise in medical technology and healthcare innovation. The company has garnered attention from prominent investors in the medical field, supporting its research and development efforts. Key achievements include advancing their pipeline programs in retinal vein occlusion and transcranial ultrasound therapies. Cerevast's impact lies in its potential to significantly improve outcomes for stroke patients through innovative, non-invasive treatment solutions.

Cerevast Therapeutics - Similar Companies

CereVasc logo

CereVasc

cerevasc.com

Cervel Neurotech logo

Cervel Neurotech

cervel.com

SonoVascular logo

SonoVascular

sonovascular.com

NeuroVasx logo

NeuroVasx

Cognition Medical logo

Cognition Medical

Cerebrotech Medical Systems logo

Cerebrotech Medical Systems

NeuRx Medical logo

NeuRx Medical

neurxmed.com

Waveclear logo

Waveclear

Nervive logo

Nervive

Neurosonics Medical logo

Neurosonics Medical

StrokeDx logo

StrokeDx

stroke-dx.com

Rist Neurovascular logo

Rist Neurovascular

ristneuro.com

Imperative Care logo

Imperative Care

Rapidpulse logo

Rapidpulse

rapidpulsemed.com

Boston Neurosciences logo

Boston Neurosciences

Cerevast Therapeutics - Quick Facts

Who are Cerevast Therapeutics' competitors?

Companies similar to Cerevast Therapeutics include CereVasc, Cervel Neurotech, SonoVascular and NeuroVasx.

When was Cerevast Therapeutics founded?

Cerevast Therapeutics was founded in 2009.

Where is Cerevast Therapeutics' headquarters located?

Cerevast Therapeutics' headquarters is located in Redmond, WA, US.

When was Cerevast Therapeutics' last funding round?

Cerevast Therapeutics' most recent funding round was for $11.4M (USD) in March 2015.

How much has Cerevast Therapeutics raised to-date?

As of Mar 6, 2015, Cerevast Therapeutics has raised a total of $24.4M (USD).

How many employees does Cerevast Therapeutics have?

Cerevast Therapeutics has 30 employees as of Feb 5, 2024.

Cerevast Therapeutics - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Ultrasound
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified